ABBV vs. ARQQ

Last updated Jun 13, 2026

ABBV (AbbVie Inc.) and ARQQ (Arqit Quantum Inc.) are both stocks. ABBV operates in Drug Manufacturers - General (Healthcare), while ARQQ operates in Software - Infrastructure (Technology). Over the past 3 years, ABBV returned 22.39%/yr vs -28.53%/yr for ARQQ. At a 0.00 correlation, their price movements are largely independent.

Performance

ABBV vs. ARQQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AbbVie Inc. (ABBV) and Arqit Quantum Inc. (ARQQ). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ABBV achieves a 1.30% return, which is significantly higher than ARQQ's -37.84% return.

ABBV

• 1D: 1.32%
• 1M: 9.22%
• YTD: 1.30%
• 6M: 3.65%
• 1Y: 22.21%
• 3Y*: 22.39%
• 5Y*: 18.94%
• 10Y*: 19.10%

ARQQ

• 1D: -0.66%
• 1M: -1.66%
• YTD: -37.84%
• 6M: -52.03%
• 1Y: -49.10%
• 3Y*: -28.53%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

ABBV vs. ARQQ - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
ABBV AbbVie Inc.	1.30%	33.08%	18.86%	-0.23%	24.01%	22.78%
ARQQ Arqit Quantum Inc.	-37.84%	-43.67%	227.76%	-86.87%	-84.93%	158.92%

Correlation

The correlation between ABBV and ARQQ is -0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.07
Correlation (3Y) Calculated over the trailing 3-year period	-0.01
Correlation (All Time) Calculated using the full available price history since Sep 7, 2021	0.00

Fundamentals

Market Cap ABBV : $403.99B ARQQ : $225.50M
EPS ABBV : $2.05 ARQQ : -$4.72
PS Ratio ABBV : 6.43 ARQQ : 151.77
PB Ratio ABBV : 14.69 ARQQ : 7.91
Total Revenue (TTM) ABBV : $62.82B ARQQ : $1.43M
Gross Profit (TTM) ABBV : $46.15B ARQQ : -$307.00K
EBITDA (TTM) ABBV : $17.96B ARQQ : -$68.30M

Return for Risk

ABBV vs. ARQQ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ABBV

ABBV Risk / Return Rank: 68
ABBV Sharpe Ratio Rank: 72
ABBV Sortino Ratio Rank: 66
ABBV Omega Ratio Rank: 65
ABBV Calmar Ratio Rank: 68
ABBV Martin Ratio Rank: 68

ARQQ

ARQQ Risk / Return Rank: 24
ARQQ Sharpe Ratio Rank: 22
ARQQ Sortino Ratio Rank: 27
ARQQ Omega Ratio Rank: 28
ARQQ Calmar Ratio Rank: 21
ARQQ Martin Ratio Rank: 25

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ABBV vs. ARQQ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for AbbVie Inc. (ABBV) and Arqit Quantum Inc. (ARQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	ABBV	ARQQ	Difference
Sharpe ratio: Return per unit of total volatility	0.92	-0.47	+1.39
Sortino ratio: Return per unit of downside risk	1.42	-0.20	+1.62
Omega ratio: Gain probability vs. loss probability	1.18	0.98	+0.20
Calmar ratio: Return relative to maximum drawdown	1.29	-0.62	+1.91
Martin ratio: Return relative to average drawdown	2.88	-0.91	+3.79

ABBV vs. ARQQ - Sharpe Ratio Comparison

The current ABBV Sharpe Ratio is 0.92, which is higher than the ARQQ Sharpe Ratio of -0.47. The chart below compares the historical Sharpe Ratios of ABBV and ARQQ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

ABBV vs. ARQQ - Drawdown Comparison

The maximum ABBV drawdown since its inception was -45.09%, smaller than the maximum ARQQ drawdown of -99.60%. Use the drawdown chart below to compare losses from any high point for ABBV and ARQQ.

Drawdown Indicators

	ABBV	ARQQ	Difference
Max Drawdown Largest peak-to-trough decline	-45.09%	-99.60%	+54.51%
Max Drawdown (1Y) Largest decline over 1 year	-17.32%	-79.78%	+62.46%
Max Drawdown (3Y) Largest decline over 3 years	-20.74%	-89.76%	+69.02%
Max Drawdown (5Y) Largest decline over 5 years	-21.92%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-45.09%	—	—
Current Drawdown Current decline from peak	-4.60%	-98.57%	+93.97%
Average Drawdown Average peak-to-trough decline	-10.71%	-88.78%	+78.07%
Ulcer Index Depth and duration of drawdowns from previous peaks	7.75%	53.78%	-46.03%

Volatility

ABBV vs. ARQQ - Volatility Comparison

The current volatility for AbbVie Inc. (ABBV) is 6.10%, while Arqit Quantum Inc. (ARQQ) has a volatility of 35.65%. This indicates that ABBV experiences smaller price fluctuations and is considered to be less risky than ARQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ABBV	ARQQ	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.10%	35.65%	-29.55%
Volatility (6M) Calculated over the trailing 6-month period	17.85%	64.49%	-46.64%
Volatility (1Y) Calculated over the trailing 1-year period	24.31%	104.65%	-80.34%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	22.89%	134.12%	-111.23%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	25.73%	134.12%	-108.39%

Dividends

ABBV vs. ARQQ - Dividend Comparison

ABBV's dividend yield for the trailing twelve months is around 2.96%, while ARQQ has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ABBV AbbVie Inc.	2.96%	2.87%	3.49%	3.82%	3.49%	3.84%	4.41%	4.83%	3.89%	2.65%	3.64%	3.41%
ARQQ Arqit Quantum Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both ABBV and ARQQ in my portfolio?

ABBV and ARQQ have a correlation of -0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ABBV or ARQQ?

ARQQ has higher volatility (35.65%) compared to ABBV (6.10%). In terms of maximum drawdown, ABBV dropped -45.09% vs ARQQ's -99.60%.

Which has better risk-adjusted returns?

ABBV currently has the higher Sharpe Ratio (0.92 vs -0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.